A detailed history of Criterion Capital Advisors, LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Criterion Capital Advisors, LLC holds 128 shares of GMED stock, worth $10,636. This represents 0.01% of its overall portfolio holdings.

Number of Shares
128
Previous 128 -0.0%
Holding current value
$10,636
Previous $8.77 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$51.15 - $56.52 $6,547 - $7,234
128 New
128 $6.87 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.4B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Criterion Capital Advisors, LLC Portfolio

Follow Criterion Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Criterion Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Criterion Capital Advisors, LLC with notifications on news.